Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Abstract
Citations
-
3 7 3
CrossRef
-
0
Web of Science
-
3 9 9
Scopus
Authors (23)
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
LANCET
no. 387,
edition 10020,
pages 770 - 778,
ISSN: 0140-6736 - ISSN:
- 0140-6736
- Publication year:
- 2016
- DOI:
- Digital Object Identifier (open in new tab) 10.1016/s0140-6736(15)00667-4
- Verified by:
- No verification
seen 98 times